Korea’s leading drug manufacturers feel pinch in prescription drug sales

Last year, the leading domestic drug makers were significantly affected by the government’s policy to abandon rebate, defined by a kind of kickback given by drug companies to pharmacies, clinics and hospital for buying their products.

These companies, such as Daewoong Pharmaceutical, Dong-A Pharmaceutical, Hanmi Pharmaceutical and Yuhan Pharm, kept their leading positions in terms of revenue...